Zobrazeno 1 - 10
of 22
pro vyhledávání: '"David M. Agarwal"'
Autor:
Lauren M. Ladd, Temel Tirkes, Mark Tann, David M. Agarwal, Matthew S. Johnson, Bilal Tahir, Kumaresan Sandrasegaran
Publikováno v:
Clinical and Molecular Hepatology, Vol 22, Iss 4, Pp 450-457 (2016)
Background/Aims The diagnosis and treatment plan for hepatocellular carcinoma (HCC) can be made from radiologic imaging. However, lesion detection may vary depending on the imaging modality. This study aims to evaluate the sensitivities of hepatic mu
Externí odkaz:
https://doaj.org/article/327829ef622144fdae0724fbf7adfc23
Autor:
Ihab I. El Hajj, John M. DeWitt, Attila Nakeeb, Jeffrey J. Easler, Evan L. Fogel, Kumar Sandrasegaran, Safi Shahda, Stuart Sherman, Susannah G. Ellsworth, Mackenzie A. Eagleson, Bert H. O'Neil, David M. Agarwal, Nicholas J. Zyromski, Michael G. House
Publikováno v:
American Journal of Gastroenterology. 112:537-554
In this article, we review our multidisciplinary approach for patients with pancreatic cancer. Specifically, we review the epidemiology, diagnosis and staging, biliary drainage techniques, selection of patients for surgery, chemotherapy, radiation th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01310f3b7decee95d1833bbc4eeb2e12
https://doi.org/10.1038/ajg.2016.610
https://doi.org/10.1038/ajg.2016.610
Autor:
David M. Agarwal, Temel Tirkes, Mark Tann, Lauren M. Ladd, Kumaresan Sandrasegaran, Matthew S. Johnson, Bilal Tahir
Publikováno v:
Clinical and Molecular Hepatology
Clinical and Molecular Hepatology, Vol 22, Iss 4, Pp 450-457 (2016)
Clinical and Molecular Hepatology, Vol 22, Iss 4, Pp 450-457 (2016)
BACKGROUND/AIMS The diagnosis and treatment plan for hepatocellular carcinoma (HCC) can be made from radiologic imaging. However, lesion detection may vary depending on the imaging modality. This study aims to evaluate the sensitivities of hepatic mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8036233af553ce14c4347a04d8f5394e
http://europepmc.org/articles/PMC5266349
http://europepmc.org/articles/PMC5266349
Autor:
Stephen V. Scheller, David M. Agarwal
While there have been many advances in surgical technique and post-operative care of patients undergoing liver transplant since the first performed in 1963, procedural complexity still require a long recovery. To compound this, relative shortage of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::889fc9c0b119a9f2508c516e2d598523
https://doi.org/10.1093/med/9780190276249.003.0033
https://doi.org/10.1093/med/9780190276249.003.0033
Autor:
David M. Agarwal, John C. McDermott, James M. Keily, Hebert Chen, Edward J. Quebbeman, Sharon M. Weber, Henry A. Pitt, Jaime Knuth, Susan C. Pitt, William S. Rilling
Publikováno v:
Journal of Gastrointestinal Surgery. 12:1951-1960
Aggressive management of hepatic neuroendocrine (NE) metastases improves symptoms and prolongs survival. Because of the rarity of these tumors, however, the best method for hepatic artery embolization has not been established. We hypothesized that in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6adc6ae7fb2343ddcceff520156c772b
https://doi.org/10.1007/s11605-008-0640-6
https://doi.org/10.1007/s11605-008-0640-6
Autor:
Paul Y. Kwo, Suthat Liangpunsakul, Huafeng Shen, Naga Chalasani, Lawrence Lumeng, Hwan Yoo, Rong Qi, David M. Agarwal
Publikováno v:
Alimentary Pharmacology & Therapeutics. 26:393-400
Summary Background Transcatheter arterial chemoembolization (TACE) has been shown to improve survival in patients with unresectable hepatocellular carcinoma (HCC). Aim To identify pretreatment factors that predicts increased mortality in HCC patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93bc92059b23fe8cad378c38fb892570
https://doi.org/10.1111/j.1365-2036.2007.03395.x
https://doi.org/10.1111/j.1365-2036.2007.03395.x
Autor:
Tim E. Taber, Muhammad S. Yaqub, Anum Ali, Dennis P. Mishler, Asif Sharfuddin, William C. Goggins, Muhammad A. Mujtaba, David M. Agarwal
Publikováno v:
Clinical transplantation. 29(9)
Our aim was to study the long-term outcomes of all transplant recipients who underwent angiography for suspected TRAS at our institution. The patients were divided into TRAS+ve and TRAS-ve groups based upon angiographically confirmed results. TRAS wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::196ef56def3dea9890ea884c4801d9ad
https://pubmed.ncbi.nlm.nih.gov/26052624
https://pubmed.ncbi.nlm.nih.gov/26052624
Autor:
Steven J. Willing, Stephen G. Lalka, David M. Agarwal, Matthew S. Johnson, Michael S. Stecker
Publikováno v:
Journal of Vascular and Interventional Radiology. 13:413-417
In this article, a patient with extensive cerebrovascular disease who had previously undergone bilateral carotid endarterectomy and subsequent operative revision on the left side is described. The patient developed critical restenosis at the cephalic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efacbf71c357d6128a295a736b4f723a
https://doi.org/10.1016/s1051-0443(07)61746-1
https://doi.org/10.1016/s1051-0443(07)61746-1
Autor:
Chandrashekhar A. Kubal, Mark Tann, Marco A. Lacerda, Bert H. O'Neil, David M. Agarwal, Mary A. Maluccio, Wenhu Pi, Yong Zang, Feng Ming Kong
Publikováno v:
Journal of Clinical Oncology. 35:e15652-e15652
e15652 Background: The evolution of treatment for HCC has seen novel therapies emerge as front line treatment alternatives. The aim of this study was to report survival in HCC patients treated within the context of a robust multidisciplinary program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e590462a48e0ed04e144e92b1f8ab3a
https://doi.org/10.1200/jco.2017.35.15_suppl.e15652
https://doi.org/10.1200/jco.2017.35.15_suppl.e15652
Autor:
Naoyuki G. Saito, David E. Long, Yong Zang, Bert H. O'Neil, Feng Ming Kong, Richard C. Zellars, David M. Agarwal, Wenhu Pi, Mark Tann, Marwan Ghabril, Mary A. Maluccio, Marco A. Lacerda, Susannah G. Ellsworth
Publikováno v:
Journal of Clinical Oncology. 35:4080-4080
4080 Background: Stereotactic Body Radiation Therapy (SBRT) has emerged as a viable treatment option in patients with hepatocellular carcinoma (HCC). This study aimed to compare survival outcomes after SBRT with other front line local treatments for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7818b36dce6d1b2d2e92f8fa401c9bd1
https://doi.org/10.1200/jco.2017.35.15_suppl.4080
https://doi.org/10.1200/jco.2017.35.15_suppl.4080